...
首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.
【24h】

Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.

机译:心律失常患者的心脏再同步的急性和慢性影响,长期起搏器治疗获得性完全房室传导阻滞。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: We assessed the effects of cardiac re-synchronization therapy (CRT) in patients who developed otherwise unexplained heart failure (HF) during right ventricular apical (RVA)-pacing for acquired complete atrioventricular block (CAVB). METHODS AND RESULTS: Eighteen consecutive CAVB patients with HF during RVA-pacing were assessed with haemodynamic studies immediately and 12 months after CRT-upgrade. Ten patients had idiopathic CAVB and 13 showed normal left ventricular (LV) function at RVA-pacemaker implantation. HF developed after 81 +/- 10 months. RVA-pacing duration correlated (r = 0.49, P < 0.05) with LV ejection fraction (LVEF) deterioration. Biventricular- (BiV) and LV-pacing acutely improved the systolic function comparably, but only BiV improved diastolic function. One-year post-CRT-initiation, New York Heart Association classification improved 35 +/- 3% (P < 0.05) and the number of hospitalizations decreased 85 +/- 3% (P < 0.0001). CRT decreased LV end-diastolic diameter (LVEDd) 7 +/- 2% (P< 0.01) and increased LVEF by 23 +/- 7% (P < 0.01). The CRT-induced reduction in LVEDd tended to be greater in patients with RVA-pacing for < 5 years vs. > 5 years (7.7 +/- 2.5 vs. 3.6 +/- 1.0 mm, P = 0.08). CONCLUSION: CRT-upgrade improves the cardiac function and symptoms in CAVB patients with HF progression related to RVA-pacing. Because adverse LV-remodelling may be partly irreversible, consideration should be given to BiV- and LV-pacing upgrade as soon as possible after the indications appear, and prospective studies of the optimal timing of CRT-upgrade may be useful.
机译:目的:我们评估了心脏再同步治疗(CRT)对右室心尖(RVA)起搏期间获得原发性完全性房室传导阻滞(CAVB)的原因不明的心力衰竭(HF)的患者的影响。方法和结果:18例RAV起搏期间连续的CAVB HF患者在CRT升级后和升级后12个月接受了血流动力学研究。 10例特发性CAVB患者,其中13例在RVA-Pacemaker植入术中显示正常的左心室(LV)功能。 HF在81 +/- 10个月后出现。 RVA起搏持续时间与LV射血分数(LVEF)恶化相关(r = 0.49,P <0.05)。 Biventricular-(BiV)和LV起搏可相当程度地改善收缩功能,但只有BiV可以改善舒张功能。 CRT启动后一年,纽约心脏协会的分类改善了35 +/- 3%(P <0.05),住院次数减少了85 +/- 3%(P <0.0001)。 CRT使左室舒张末期直径(LVEDd)降低7 +/- 2%(P <0.01),使LVEF增加23 +/- 7%(P <0.01)。 RVA起搏<5年vs> 5年的患者,CRT引起的LVEDd降低往往更大(7.7 +/- 2.5 vs. 3.6 +/- 1.0 mm,P = 0.08)。结论:CRT升级可改善伴RVA起搏的HF进展的CAVB患者的心脏功能和症状。由于不良的左心室重塑可能在某种程度上是不可逆的,因此应在适应症出现后尽快考虑BiV和左心室搏动的升级,对CRT升级的最佳时机进行前瞻性研究可能是有用的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号